Concepedia

Hisanori Takenobu

HT

15

Publications

722

Citations

14

H-Index

2003

Active since

Affiliations

Chiba Cancer Center(Current)

Chiba University

National Center For Child Health and Development

Saitama Cancer Center

Saitama University

Hisanori Takenobu is an author at Chiba Cancer Center specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2003–2023

15

Publications

15

CD133 suppresses neuroblastoma cell differentiation via signal pathway modification

Hisanori Takenobu, Osamu Shimozato, Takafumi Nakamura et al. · Oncogene · 2010 · 127 citations

, , +6

Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1B β and TSLC1 in neuroblastoma

Hirotaka Ochiai, Hisanori Takenobu, Atsuko Nakagawa et al. · Oncogene · 2010 · 83 citations

, , +9

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications

Zhenghao Li, Hisanori Takenobu, Amallia Nuggetsiana Setyawati et al. · Oncogene · 2018 · 78 citations · Full text

The secreted form of the p40 subunit of interleukin (IL)‐12 inhibits IL‐23 functions and abrogates IL‐23‐mediated antitumour effects

Osamu Shimozato, Shin‐ichi Ugai, Masako Chiyo et al. · Immunology · 2005 · 76 citations · Full text

, , +19

The Stress- and Inflammatory Cytokine-induced Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor Is Mediated by p38 MAPK, Distinct from the 12-O-Tetradecanoylphorbol-13-acetate- and Lysophosphatidic Acid-induced Signaling Cascades

Hisanori Takenobu, Ayano Yamazaki, Michinari Hirata et al. · Journal of Biological Chemistry · 2003 · 72 citations · Full text

Rows per page

1–5 of 15